ANI Pharmaceuticals, Inc. (ANIP) total debt

Total debt · fiscal 2025
$617.04M

ANI Pharmaceuticals, Inc. (ANIP) carried total debt of $617.04M at the end of fiscal 2025 (December 31, 2025). That is 1.1% lower than the $624.09M of fiscal 2024. Figures as of 18 Nov 2026, 04:04 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$617.04M
Change on fiscal 2024
−1.1%
Growth, 5 years
+27.1% a year
Growth, 10 years
+18.5% a year
Highest on record
$624.09Mfiscal 2024
Lowest on record
$70.55Mfiscal 2018
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ANI Pharmaceuticals, Inc. total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 27.1% a year; over ten years the rate was 18.5% a year. Across the 12 fiscal years on record (2014–2025), the highest was $624.09M in fiscal 2024 and the lowest $70.55M in fiscal 2018.

Total debt was 1.1× shareholders' equity at the end of fiscal 2025.

History · 12 fiscal years

Total debt by fiscal year

ANI Pharmaceuticals, Inc. total debt, year by year

ANI Pharmaceuticals, Inc. (ANIP) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$617.04M 1.1% down1.1×
2024$624.09M 118.5% up1.5×
2023$285.67M 0.3% down0.6×
2022$286.52M 0.3% down0.8×
2021$287.37M 54.8% up0.9×
2020$185.69M 0.0% down0.9×
2019$185.75M 163.3% up0.9×
2018$70.55M 45.0% down0.4×
2017$128.21M 6.3% up0.7×
2016$120.64M 6.4% up0.7×
2015$113.43M 6.5% up0.7×
2014$106.54M—0.8×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on ANIP

ANI Pharmaceuticals, Inc., figure by figure

ANI Pharmaceuticals, Inc. (ANIP) overview: price, valuation and scorecard

ANI Pharmaceuticals, Inc. total debt: questions and answers

How much debt does ANI Pharmaceuticals, Inc. have?

ANI Pharmaceuticals, Inc. (ANIP) carried total debt of $617.04M at the end of fiscal 2025 (December 31, 2025). That is 1.1% lower than the $624.09M of fiscal 2024.

What is the growth rate of ANI Pharmaceuticals, Inc.'s total debt?

Over the five fiscal years to 2025 total debt grew at a compound 27.1% a year; over ten years the rate was 18.5% a year.

What are the highest and lowest total debt figures on record for ANI Pharmaceuticals, Inc.?

Across the 12 fiscal years on record (2014–2025), the highest was $624.09M in fiscal 2024 and the lowest $70.55M in fiscal 2018.

How does ANI Pharmaceuticals, Inc.'s debt compare with its equity?

Total debt was 1.1× shareholders' equity at the end of fiscal 2025.

How is ANI Pharmaceuticals, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ANI Pharmaceuticals, Inc. (ANIP) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/ANIP/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.